Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

12,629 public trials 2,161 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Completed

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT03422822

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • University of Alabama at Birmingham - Dermatology Research Clinic Birmingham, Alabama, United States
  • University of Alabama at Birmingham Hospital Outreach Lab Birmingham, Alabama, United States
View all 539 locations
View Trial Details
Completed

Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia

NCT05879224

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +18 more
Locations
  • Puskesmas Hanura Hanura, Lampung, Indonesia
  • Puskesmas Tanjung Leidong Labuhanbatu, North Sumatra, Indonesia
  • Puskesmas Bhintuka Mimika, Special Region of Papua, Indonesia
  • Puskesmas Pasar Sentral Mimika, Special Region of Papua, Indonesia
View Trial Details
Completed

Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS

NCT04697381

Conditions
Abnormalities, Multiple, Chromosome Disorders, Congenital Abnormalities, +13 more
Locations
  • Kanagawa Children's Medical Center Yokohama, Kanagawa, Japan
  • Osaka Women's and Children's Hospital Izumi, Osaka, Japan
  • Dokkyo Medical University Saitama Medical Center Koshigaya, Saitama, Japan
  • Hamamatsu University Hospital Hamamatsu, Shizuoka, Japan
View Trial Details
Completed

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia

NCT02961218

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Novartis Investigative Site Atlanta, Georgia, United States
  • Novartis Investigative Site Augusta, Georgia, United States
  • Novartis Investigative Site Greenville, North Carolina, United States
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 15 locations
View Trial Details
Completed

Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam

NCT05386680

Conditions
Atrophy, Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, +19 more
Locations
  • Boston Childrens Hospital Boston, Massachusetts, United States
  • Child Hosp Of The Kings Daughters Norfolk, Virginia, United States
  • University of Wisconsin Madison Medical School Madison, Wisconsin, United States
  • Novartis Investigative Site Parkville, Victoria, Australia
View all 13 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism

NCT03938454

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations
  • University Of Alabama Birmingham, Alabama, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Childrens National Hospital Washington D.C., District of Columbia, United States
  • Foundation for Sickle Cell Disease Research Hollywood, Florida, United States
View all 13 locations
View Trial Details

Related conditions